held preclinical contract research organization located in Berlin, in the heart of an environment that is unique in Europe; research and development is taking place in five universities, three university of applied sciences and in more than 20 research institutes. Berlin-Brandenburg has 30 pharmaceutical, 215 biotech and 280 medical device companies. More info.
BLS serves the in vivo preclinical research needs of several international industries.
The success of BLS research is attributed to effective teamwork among its employees and its network, who are committed to assuring that the company is the best in its field.
offers a wide range of high quality preclinical researches in vivo.
BLS staff have extensive experiences of designing large and specialezed in vivo studies where untraditional ways to tackle problems. BLS works flexibly and adapts the studies to customer's project needs. Thereby, BLS takes care of the
creativity needed to identify new and robust models for the preclinical phase. BLS's experience from small and large projects within many different diseases makes possible a fast and effective delivery of data to customers.
BLS exists to provide comprehensive in vivo research that meets the requirements of pharmaceutical, biotechnology, and medical device companies as we partner to bring safer products to the world.
Our goal is to ensure responsive service while providing high quality and on-time research that is tailored to our sponsor’s need to discover, develop, enhance products in a state-of-the-art environment.
BLS has conducted numerous studies for national and international companies in the field of biopharmaceutical products and medical devices.
Our in vivo services include:
• Development of preclinical strategies
• Pilot in vivo studies
• Proof-of-concept studies
• Pharmacokinetic studies
• Hematology / clinical chemistry
• Histopathology / histomorphometry
• Medical device biocompatibility testing